Molecure S.A. (MOC) - Cash Flow Conversion Efficiency

Latest as of March 2025: 0.266x

Based on the latest financial reports, Molecure S.A. (MOC) has a cash flow conversion efficiency ratio of 0.266x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł26.15 Million ≈ $7.20 Million USD) by net assets (zł98.21 Million ≈ $27.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Molecure S.A. - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Molecure S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Molecure S.A. carry for a breakdown of total debt and financial obligations.

Molecure S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Molecure S.A. ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sapmer PA:ALMER	0.116x
Sunnic Technology & Merchandise TWO:3360	-0.120x
TBC Bank Group PLC LSE:TBCG	0.010x
Ortoma AB Series B ST:ORT-B	-0.066x
Usio Inc NASDAQ:USIO	0.016x
Ironbark Capital Ltd AU:IBC	0.031x
Poulaillon SA PA:ALPOU	0.198x
Cineline India Limited NSE:CINELINE	0.036x

Annual Cash Flow Conversion Efficiency for Molecure S.A. (2015–2024)

The table below shows the annual cash flow conversion efficiency of Molecure S.A. from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see Molecure S.A. (MOC) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł103.41 Million ≈ $28.46 Million	zł-56.99 Million ≈ $-15.68 Million	-0.551x	-138.84%
2023-12-31	zł100.93 Million ≈ $27.78 Million	zł-23.29 Million ≈ $-6.41 Million	-0.231x	-185.69%
2022-12-31	zł126.45 Million ≈ $34.80 Million	zł-10.21 Million ≈ $-2.81 Million	-0.081x	+15.53%
2021-12-31	zł141.14 Million ≈ $38.84 Million	zł-13.50 Million ≈ $-3.71 Million	-0.096x	-123.87%
2020-12-31	zł143.40 Million ≈ $39.47 Million	zł57.44 Million ≈ $15.81 Million	0.401x	+545.88%
2019-12-31	zł79.13 Million ≈ $21.78 Million	zł-7.11 Million ≈ $-1.96 Million	-0.090x	-50.45%
2018-12-31	zł81.89 Million ≈ $22.54 Million	zł-4.89 Million ≈ $-1.35 Million	-0.060x	-195.95%
2017-12-31	zł29.72 Million ≈ $8.18 Million	zł-599.63K ≈ $-165.03K	-0.020x	+81.79%
2016-12-31	zł13.01 Million ≈ $3.58 Million	zł-1.44 Million ≈ $-396.50K	-0.111x	-11.67%
2015-12-31	zł15.43 Million ≈ $4.25 Million	zł-1.53 Million ≈ $-421.14K	-0.099x	--

About Molecure S.A.

WAR:MOC Poland Biotechnology

Market Cap

$31.98 Million

zł116.20 Million PLN

Market Cap Rank

#23507 Global

#219 in Poland

Share Price

zł5.64

Change (1 day)

+0.36%

52-Week Range

zł5.11 - zł8.79

All Time High

zł69.60